Avatrombopag Doptelet® |
Formulary
|
Tablets 20mg
NICE TA853 for treating primary chronic immune thrombocytopenia - see link below |
NICE TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure NICE TA853: Avatrombopag for treating primary chronic immune thrombocytopenia |
|
Caplacizumab Cablivi® |
Formulary
|
10mg powder and solvent for solution for injection |
NICE TA667: Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura |
|
Eltrombopag Revolade® |
Formulary
|
Tablets 25mg, 50mg |
MHRA: Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results NICE TA293: Eltrombopag for treating chronic immune thrombocytopenia NICE TA382: Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) |
|
Fostamatinib TAVLESSE ® |
Formulary
|
Film coated tablets, 100mg, 150mg |
NICE TA935: Fostamatinib for treating refractory chronic immune thrombocytopenia |
|
Lusutrombopag Mulpleo® |
Formulary
|
Film coated tablets 3mg |
NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure |
|
Romiplostim Nplate® |
Formulary
|
Injection 250 micrograms |
NICE TA221: Romiplostim for the treatment of chronic immune thrombocytopenia |
|